Caribou Biosciences, Inc. Share Price

Caribou Biosciences, Inc. Share Price

NASDAQ: CRBU | Micro Cap
$0.45
-$0.04 (-7.84%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Caribou Biosciences, Inc. Stock Performance

Open
$0.48
Prev. Close
$0.48
Circuit Range
N/A
Day Range
$0.45 - $0.49
Year Range
$0.44 - $3.54
Volume
43,280
Average Traded
$0.46

Caribou Biosciences, Inc. Share Price Today

As of 30 October 2026, Caribou Biosciences, Inc.'s share price is $0.45. The stock opened at $0.48, compared to its previous close of $0.48. During today's trading session, Caribou Biosciences, Inc.'s share price traded between $0.45 and $0.49, with an average price of $0.47. Over the past 52 weeks, the stock has recorded a high of $3.54 and a low of $0.44. In terms of performance, Caribou Biosciences, Inc.'s share price has declined by 76.49% over the last six months and is down 81.67% on a year-on-year basis.

Caribou Biosciences, Inc. Share Price Chart

Line chart of the Caribou Biosciences, Inc. price trend over the selected period. The price fell overall, ranging from 0.45 to 0.49, ending at 0.45.
$0.45$0.49
L
Show Current Price
H

Caribou Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$41.60M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.97
Revenue (TTM)
$11.16B
Return On Equity (TTM)
-105.56%
Profit Margin
-1328.67%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
11.87%

Caribou Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.20$3.94$2.40$1.50
Net Profit-$27.55-$26.64-$25.09-$24.28
Net Profit Margin-1252.27%-676.14%-1045.42%-1618.67%
Income ChangeN/A3.30%5.82%3.23%

Caribou Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.85$34.48$9.99$11.16
Net Profit-$99.42-$102.07-$148.88-$148.28
Net Profit Margin-717.83%-296.03%-1490.29%-1328.67%
Income ChangeN/A-2.67%-45.86%0.40%

About Caribou Biosciences, Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Caribou Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.28
$0.45
-64.88%
Sep 2026
$1.53
$1.27
-23.03%
Aug 2026
$1.47
$1.65
+13.79%
Jul 2026
$1.77
$1.45
-17.14%
Jun 2026
$2.35
$1.75
-25.53%
May 2026
$1.86
$2.35
+24.01%
Apr 2026
$1.97
$1.90
-0.26%
Mar 2026
$1.79
$1.90
+0.26%
Feb 2026
$1.40
$1.90
+35.36%
Jan 2026
$1.58
$1.40
-11.67%
Dec 2025
$1.84
$1.58
-18.30%
Nov 2025
$3.40
$1.94
-20.16%

CRBU Share Price FAQs